Navigation Links
Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
Date:5/27/2009

NEW BRUNSWICK, N.J., May 27 /PRNewswire-FirstCall/ -- In an arbitration demand filed today with the American Arbitration Association, Johnson & Johnson (NYSE: JNJ) has requested a ruling that the agreement and plan of merger between Merck & Co., Inc., and Schering-Plough Corporation constitutes a change of control that would permit the termination of the agreements between Schering-Plough and Johnson & Johnson's subsidiary Centocor Ortho Biotech Inc., regarding the product REMICADE(R) (infliximab), a well-established biologic product for inflammatory/immunological diseases, and SIMPONI(TM) (golimumab), a next-generation treatment. The termination of the agreements would return full rights to Johnson & Johnson for the distribution of these products in markets outside the United States where Schering-Plough currently has the rights to distribute these products.

"As its public statements have made clear, Merck is acquiring Schering-Plough," the company said. "The acquisition constitutes a change of control that triggers the right of our Centocor Ortho Biotech subsidiary to terminate the agreements."

About Johnson & Johnson

Caring for the world, one person at a time...inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.


'/>"/>
SOURCE Johnson & Johnson
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Boston Scientific Announces Two Directors Leave Board as Burns Named CEO of Xerox and Johnson Confirmed as Under Secretary of Energy
2. Champions Shawn Johnson & Phil Jackson Wear Energy Muse Jewelry
3. Johnson & Johnson to Participate in Deutsche Bank 34th Annual Health Care Conference
4. Johnson & Johnson to Host Analyst Conference Call To Review Six-Month Trial Results From NEVO RES I
5. EF Johnson Technologies, Inc. Announces First Quarter 2009 Financial Results
6. Johnson & Johnson to Participate in Bank of America and Merrill Lynch 2009 Health Care Conference
7. Weill Cornell and Cornells Johnson School present first annual business and medicine symposium
8. Johnson & Johnson to Webcast Annual Meeting of Shareholders
9. Johnson & Johnson Reports 2009 First-Quarter Results:
10. Trust for Americas Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America
11. Practice Greenhealth Enters Partnership with Johnson & Johnson for Health Care Sustainability Research and Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Va. (PRWEB) September 16, 2014 ... through predictive analytics and targeted clinical programs, today ... announced changes support the Company’s drive to improve ... and targeted clinical programs. On September 2, 2014, ... company, Millennium Health, announced that RxAnte founder and ...
(Date:9/16/2014)... TUESDAY, Sept. 16, 2014 (HealthDay News) -- Illegal drug use ... according to a new federal report. Encouragingly, the ... the use of tobacco products among young people between the ... 2013. The annual survey of 70,000 people aged 12 ... and 2013, substance dependence or abuse problems among this age ...
(Date:9/16/2014)... NEW YORK, NY (September 16, 2014) The ... received the 2014 Higher Education Excellence in Diversity ... oldest and largest diversity-focused publication in higher education. ... national honor recognizing U.S. colleges and universities that ... will be featured along with 82 other recipients ...
(Date:9/16/2014)... 2014A prospective study that compared patient-reported outcomes of ... metastases demonstrates that single fraction radiation therapy (SFRT) ... therapy (MFRT) when pain, function and quality of ... at the American Society for Radiation Oncology,s (ASTRO,s) ... improvements in patients, pain, function and degree of ...
(Date:9/16/2014)... Fresh shiitake mushrooms are a ... They are second-most consumed mushroom worldwide, for their ... and health properties. , In addition to their ... and strengthen the immune system and fight flu ... beta glucans . These medicinal properties have ...
Breaking Medicine News(10 mins):Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 3Health News:Fewer U.S. Teens Using Illegal Drugs and Alcohol, Report Finds 2Health News:Columbia University College of Dental Medicine receives diversity award 2Health News:Columbia University College of Dental Medicine receives diversity award 3Health News:Columbia University College of Dental Medicine receives diversity award 4Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 2Health News:As Fall Schedules Settle In, Block Stress-Related Illness with Your Own Shiitake Mushroom Log Kit from Lost Creek Mushroom Farm 3
... of their work linking mutations in BRAC2 gene leading to ... Journal of Medical Ethics. //Mutations in BRAC2 gene which was ... women has now found to increase the risk of development ... the study also confirmed the relation between BRAC2 mutations and ...
... population its possible to drive safely if they take ... latest edition of Harvard Men's Health Watch, chronic illnesses ... for auto accidents. Even normal, healthy aging can take ... sensory abilities. But simple preparations and precautions can help ...
... risk of picking up infections like MRSA if they glucose ... recent issue of the journal Thorax.// ,The authors base ... in intensive care who required mechanical help with their breathing ... medical and surgical specialties., ,Levels of glucose were measured ...
... from Johns Hopkins had found that patients, who are treated ... follow all the advice of their physicians for effective treatment ... of more than 5,000 Americans, those who said they were ... likely to report higher levels of satisfaction with their care, ...
... have discovered the brain patterns associated with amusia or tone ... associated with other learning disorders like dyslexia. // ... are tone deaf -- in scientific terms, suffering from amusia ... note from another. The disorder can be congenital, present from ...
... before. The problem seems to be worse now that scientists ... proves, when it comes to being overweight, past is most ... shows that we can't afford to wait," said Vivien Morris, ... that brought the girls to the health center's pool, a ...
Cached Medicine News:Health News:Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions 2Health News:Early Awareness About Weight Management Needed To Tackle Lifelong Obesity 2
(Date:9/16/2014)... MELVILLE, N.Y. , Sept. 16, 2014 /PRNewswire/ ... ), the world,s largest provider of health care ... and medical practitioners, announced today that Stanley M. ... Officer, will participate in a healthcare services panel ... 2014.  Joining Mr. Bergman will be Dr. Stohler, ...
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... the Hereditary Neuropathy Foundation (HNF) announced today an agreement ... Charcot-Marie-Tooth (CMT) disease and support the development of a ... Pharnext will provide financial support to several HNF,s initiatives ... a specific section in the HNF website featuring  HNF ...
(Date:9/15/2014)...  Alere Inc. (NYSE: ALR ) (the ... toxicology, cardiology and diabetes products and services, today confirmed ... CEO Ron Zwanziger , filed a Schedule 13D ... a letter to Gregg J. Powers , Chairman ... in an effort to secure financing to make a ...
Breaking Medicine Technology:Henry Schein To Present At The Leerink Partners Services Roundtable 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Alere Responds To Letter From Former Executives 2
... resistance ... in small cell lung cancer -, SOUTH SAN FRANCISCO, Calif., ... company focused,on oncology, today announced that preliminary data from a Phase ... tumors will be,presented at the 2008 American Association for Cancer Research ...
... BRUSSELS and NEWARK, New Jersey, March 19 ... the UMDNJ-University Hospital,(UH) in Newark, New Jersey from ... interventions to improve outpatient care and,access for people ... teaching hospital provides care for a low-income, minority,population ...
Cached Medicine Technology:Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting 2Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting 3UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 2UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 3UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation 4
the LabOne Healthcare Group markets laboratory testing to physicians, patients, managed care companies, self-insured employers, wellness companies and hospitals....
... ideal hemostatic gauze for a variety of inpatient ... iX is easy to handle and can be ... sites that are often a challenge faced by ... used to control bleeding in outpatient procedures such ...
Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
Microscissors : Horizontal Scissors...
Medicine Products: